Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press coverage in Publications and Media, and critical scientific insights within Industry News.

April Edition: Cancer Research Industry News

Cancer Research Industry News discusses the benefits of using humanized mice with Taconic Biosciences' Dr. Michael Seiler: "Q: Can you give us an overview of the humanized mice product offering at Taconic? A: The humanized mouse program at Taconic generates three models all based on the super immune deficient CIEA NOG mouse platform. To generate short term models of immune system function, we engraft human PBMC (peripheral...

Read More

Choosing CRISPR-based screens in cancer

Nature features critical commentary on CRISPR from Taconic Biosciences' Dr. John Couse: "Many possibilities for parsing cancer emerge when labs combine gene editing and screens. And RNAi retains its spot in the menu of options." Read* the complete article at: Nature.com *Registration required to view complete article...

Read More

Taconic Biosciences Launches ExpressMODEL®, A New Accelerated Model Generation Service

Hudson, NY — March 31, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, has launched ExpressMODEL®, an innovative and streamlined model generation service that reduces the timeline to first generation and experimental cohort by up to four months. This novel model generation method significantly reduces the time required to create an experimental rodent cohort, enabling critical drug discovery testing to...

Read More

Taconic Announces Sponsorship of 2017 Translational Microbiome Conference

Leading Discussions on Key Animal Model Considerations for Studying the Microbiome Hudson, NY — March 13, 2017 - Taconic Biosciences, the only commercial provider of germ free rodent models, announced that it will sponsor the Translational Microbiome Conference to be held in Boston April 11-13, 2017. This three-day conference will focus on the potential for translational intervention in microbiome research and the challenges associated with successful microbiome...

Read More

Taconic Biosciences Announces Expansion of Key Immunodeficient Animal Model Production

Hudson, NY — March 9, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced that effective March 1, 2017 it will expand the offering of two key immunodeficient mouse models, Rag2/Il2rg double knockout and fully congenic C57BL/6NTac Rag2 knockout. This expansion capitalizes on the duel demands for European production of immunodeficient models as well as the need for increasingly stringent...

Read More

Assessing Host-Microbiota Relationships

Genetic Engineering & Biotechnology News spotlights Taconic Biosciences' Alexander Maue, PhD, who is an expert on the microbiome: "Microbes have long had the knack of making themselves at home. In fact, these versatile and adaptable life forms are known to have preceded us by billions of years, exploiting virtually every niche on the planet. Microbes will in all likelihood survive us, too. In the meantime, they are...

Read More

Targeting Gut Bacteria May Be The Key To Preventing Alzheimer's

Huffington Post speaks of a new study which proposes a link between the brain and how a gut-healthy diet could help prevent the development of Alzheimer's disease: "Mounting research continues to show the links between the health of the gut and that of the brain. Now, a new study from Lund University in Sweden finds that unhealthy intestinal flora can accelerate the development of Alzheimer's disease. The...

Read More

Taconic Biosciences Generates Vici Syndrome Mouse Model

CRISPR Accelerates Availability of Vital Research Tool Hudson, NY — February 17, 2017 - Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, announced it has generated a novel mouse model of Vici syndrome for use by two investigators studying this rare disease. As a corporate sponsor of the Rare Disease Science Challenge: BeHEARD, hosted by the Rare Genomics Institute, Taconic donated model...

Read More

Mouse model program looks to speed drug discovery

Outsourcing-Pharma discusses the EZcohort® program launched at Taconic Biosciences: "According to the company, the EZcohort® program was developed in response to "a need for speed and predictability in drug discovery." Dr. Michael Seiler, portfolio director, Commercial Genetically Engineered Models, Taconic Biosciences, told us the company has "innovated in the transactional space." "Instead of requiring materials transfer agreements, as many repository vendors do, we sell these under a...

Read More

Taconic Biosciences Launches New EZcohort® Program Improving Access to Mouse Models

Hudson, NY - February 8, 2017 - Taconic Biosciences, a global leader in genetically engineered murine models and associated services, announced the launch of the EZcohort® program, providing researchers faster and easier access to unique mouse models. In response to the need for speed and predictability in drug discovery, the EZcohort® program leverages simplified legal documentation and common cohort sizes, allowing researchers to easily access unique cryopreserved...

Read More